Pathologic confirmation of retinal ganglion cell loss in multiple system atrophy

Please use this identifier to cite or link to this item: http://hdl.handle.net/10045/74475
Información del item - Informació de l'item - Item information
Title: Pathologic confirmation of retinal ganglion cell loss in multiple system atrophy
Authors: Mendoza-Santiesteban, Carlos E. | Palma, Jose-Alberto | Ortuño Lizarán, Isabel | Cuenca, Nicolás | Kaufmann, Horacio
Research Group/s: Neurobiología del Sistema Visual y Terapia de Enfermedades Neurodegenerativas (NEUROVIS)
Center, Department or Service: Universidad de Alicante. Departamento de Fisiología, Genética y Microbiología
Keywords: Multiple system atrophy | Retinal ganglion cell loss
Knowledge Area: Fisiología | Biología Celular
Issue Date: 6-Jun-2017
Publisher: American Academy of Neurology
Citation: Neurology. 2017, 88(23): 2233-2235. doi:10.1212/WNL.0000000000004020
Abstract: Multiple system atrophy (MSA) is a rare adult-onset rapidly progressive fatal neurodegenerative disorder characterized by the abnormal aggregation of misfolded α-synuclein primarily in oligodendrocytes.
Sponsor: NIH (U54-NS065736-01), Multiple System Atrophy Coalition, Michael J. Fox Foundation, Dysautonomia Foundation, Regional Government of Valencia (Prometeo 2016/158), Spanish Health Research Institute Carlos III (ISCIII RETICS-FEDER RD12/0034/0010), Ministry of Economy of Spain (MINECO-FEDER-BFU2015-67139-R), and Ministry of Education of Spain (FPU14/03166).
URI: http://hdl.handle.net/10045/74475
ISSN: 0028-3878 (Print) | 1526-632X (Online)
DOI: 10.1212/WNL.0000000000004020
Language: eng
Type: info:eu-repo/semantics/article
Rights: © 2017 American Academy of Neurology
Peer Review: si
Publisher version: https://doi.org/10.1212/WNL.0000000000004020
Appears in Collections:INV - NEUROVIS - Artículos de Revistas

Files in This Item:
Files in This Item:
File Description SizeFormat 
Thumbnail2017_Mendoza_etal_Neurology_final.pdf440,76 kBAdobe PDFOpen Preview


Items in RUA are protected by copyright, with all rights reserved, unless otherwise indicated.